Correlation Between Bone Biologics and Nexalin Technology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bone Biologics and Nexalin Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bone Biologics and Nexalin Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bone Biologics Corp and Nexalin Technology, you can compare the effects of market volatilities on Bone Biologics and Nexalin Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bone Biologics with a short position of Nexalin Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bone Biologics and Nexalin Technology.

Diversification Opportunities for Bone Biologics and Nexalin Technology

-0.87
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bone and Nexalin is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding Bone Biologics Corp and Nexalin Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nexalin Technology and Bone Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bone Biologics Corp are associated (or correlated) with Nexalin Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nexalin Technology has no effect on the direction of Bone Biologics i.e., Bone Biologics and Nexalin Technology go up and down completely randomly.

Pair Corralation between Bone Biologics and Nexalin Technology

Assuming the 90 days horizon Bone Biologics is expected to generate 2.17 times less return on investment than Nexalin Technology. In addition to that, Bone Biologics is 1.94 times more volatile than Nexalin Technology. It trades about 0.06 of its total potential returns per unit of risk. Nexalin Technology is currently generating about 0.24 per unit of volatility. If you would invest  93.00  in Nexalin Technology on August 28, 2024 and sell it today you would earn a total of  297.00  from holding Nexalin Technology or generate 319.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Bone Biologics Corp  vs.  Nexalin Technology

 Performance 
       Timeline  
Bone Biologics Corp 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Bone Biologics Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, Bone Biologics showed solid returns over the last few months and may actually be approaching a breakup point.
Nexalin Technology 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Nexalin Technology are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite quite abnormal basic indicators, Nexalin Technology disclosed solid returns over the last few months and may actually be approaching a breakup point.

Bone Biologics and Nexalin Technology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bone Biologics and Nexalin Technology

The main advantage of trading using opposite Bone Biologics and Nexalin Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bone Biologics position performs unexpectedly, Nexalin Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nexalin Technology will offset losses from the drop in Nexalin Technology's long position.
The idea behind Bone Biologics Corp and Nexalin Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years